Physician profile
Steven Seizer
NPI 1942236906
$5,546.24
in general payments reported to CMS, 2019-2025
39 companies · $1,626 in 2025
The $1,626 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2020: $268 · 2021: $136 · 2022: $712 · 2023: $917 · 2024: $1,362 · 2025: $1,626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,905.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $749.74 | 2019-2025 | Evenity, Prolia, Otezla |
| Lilly USA, LLC | $629.39 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $600.84 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals Lp | $507.02 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Bayer Healthcare Pharmaceuticals INC. | $409.49 | 2024-2025 | |
| Abbvie INC. | $359.69 | 2022-2025 | Synthroid |
| Pfizer INC. | $323.88 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $277.17 | 2022-2025 | |
| Bausch Health US, LLC | $210.41 | 2024-2025 | Aplenzin, Wellbutrin |
| Glaxosmithkline, LLC. | $193.47 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Biohaven Pharmaceutical Holding Company Ltd. | $120.75 | 2022 | |
| Intuitive Surgical, INC. | $105.75 | 2022 | |
| Almatica Pharma LLC | $89.63 | 2023-2024 | Loreev Xr, Teriparatide, Gralise |
| Idorsia Pharmaceuticals US INC | $88.86 | 2022-2024 | Quviviq |
| Astellas Pharma US INC | $87.89 | 2022-2024 | Veozah |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Seizer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.